AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22159381 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse breech extraction
Number of subjects: 118
Study 22159381 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (control)
Number of subjects: 118
Study 22159381 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 118
Study 19389714 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg/kg daptomycin administered as a 30 min iv infusion
Number of subjects: 55
Study 19389714 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg/kg daptomycin administered as a 2 min iv injection
Number of subjects: 55
Study 19389714 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg/kg daptomycin administered as a 2 min iv injection
Number of subjects: 55
Study 19389714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 19046587 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine (60g/day)
Number of subjects: 24
Study 19046587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 19046587 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine
Number of subjects: 24
Study 15036854 — intervention group
Group type: EXPERIMENTAL
Intervention: Cs-137 low-dose-rate brachytherapy (60-75 Gy at 1.4-1.8 Gy/h)
Number of subjects: 517
Study 15036854 — intervention group
Group type: COMPARATOR
Intervention: Ra-226 low-dose-rate brachytherapy (75 Gy at 0.5 Gy/h)
Number of subjects: 517
Study 12205256 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroxine (T4) treatment
Number of subjects: 200
Study 12205256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 9220504 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl
Number of subjects: 42
Study 9220504 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl combined with midazolam
Number of subjects: 42
Study 9220504 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular meperidine‐promethazine‐chlorpromazine (MPC) compound
Number of subjects: 42
Study 8380697 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincristine, ifosfamide, mesna and carboplatin (VIMP)
Number of subjects: 68
Study 8380697 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide, doxorubicin and etoposide (CDE)
Number of subjects: 68
Study 2443087 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% NaCl (12 mL/kg)
Number of subjects: 0
Study 2443087 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% NaCl/dextran 70 (250 mL)
Number of subjects: 0
Study 2443087 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's solution
Number of subjects: 0
Study 12362423 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) 2 gm/kg at induction and 1 gm/kg after 3 weeks
Number of subjects: 15
Study 12362423 — intervention group
Group type: COMPARATOR
Intervention: 5% albumin placebo
Number of subjects: 15
Study 30175333 — intervention group
Group type: EXPERIMENTAL
Intervention: Active varnish (Fluor Protector S; 7,700 ppm F)
Number of subjects: 12
Study 30175333 — intervention group
Group type: COMPARATOR
Intervention: Placebo varnish
Number of subjects: 12
Study 27411331 — intervention group
Group type: EXPERIMENTAL
Intervention: mindfulness intervention
Number of subjects: 68
Study 27411331 — intervention group
Group type: COMPARATOR
Intervention: relaxation intervention
Number of subjects: 68
Study 24886348 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus auricular acupressure (AA group)
Number of subjects: 206
Study 24886348 — intervention group
Group type: COMPARATOR
Intervention: Climen (control group)
Number of subjects: 206
Study 22672587 — intervention group
Group type: EXPERIMENTAL
Intervention: Change4Life (C4L) campaign materials including print materials and personalized feedback from the 'How are the Kids' questionnaire.
Number of subjects: 3774
Study 22672587 — intervention group
Group type: EXPERIMENTAL
Intervention: Change4Life (C4L) campaign materials.
Number of subjects: 3774
Study 22672587 — intervention group
Group type: EXPERIMENTAL
Intervention: Change4Life (C4L) campaign materials with personalized feedback.
Number of subjects: 3774
Study 22672587 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care).
Number of subjects: 3774
Study 20666811 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Inspection
Number of subjects: 54
Study 20666811 — intervention group
Group type: EXPERIMENTAL
Intervention: Curettage
Number of subjects: 54
Study 20666811 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermoscopy
Number of subjects: 54
Study 18811573 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic nephrectomy (LN group)
Number of subjects: 52
Study 18811573 — intervention group
Group type: COMPARATOR
Intervention: Open nephrectomy (ON group)
Number of subjects: 52
Study 16043828 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin and paclitaxel with erlotinib
Number of subjects: 274
Study 16043828 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin and paclitaxel with placebo
Number of subjects: 274
Study 12443959 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-generation oral contraceptives (specific dosage and duration not mentioned)
Number of subjects: 186
Study 10496384 — intervention group
Group type: EXPERIMENTAL
Intervention: AGIS method
Number of subjects: 56
Study 10496384 — intervention group
Group type: EXPERIMENTAL
Intervention: CIGTS method
Number of subjects: 56
Study 10496384 — intervention group
Group type: EXPERIMENTAL
Intervention: EMGT method
Number of subjects: 56
Study 10496384 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical assessment
Number of subjects: 56
Study 7729632 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening (colonoscopy or barium enema and sigmoidoscopy every 3 years)
Number of subjects: 251
Study 7729632 — intervention group
Group type: COMPARATOR
Intervention: Control (no screening)
Number of subjects: 251
Study 7729632 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality in study group
Number of subjects: 251
Study 7729632 — intervention group
Group type: COMPARATOR
Intervention: Overall mortality in control group
Number of subjects: 251
Study 1781523 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (two doses)
Number of subjects: 0
Study 1781523 — intervention group
Group type: COMPARATOR
Intervention: Saline (inert treatment)
Number of subjects: 0
Study 7008894 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical povidone-iodine
Number of subjects: 627
Study 7008894 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 627
Study 30579372 — intervention group
Group type: EXPERIMENTAL
Intervention: Precooling (PC)
Number of subjects: 12
Study 30579372 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 12
Study 28560779 — intervention group
Group type: COMPARATOR
Intervention: S‐(‐)‐amlodipine 2.5 mg/d (low dose)
Number of subjects: 523
Study 28560779 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐(‐)‐amlodipine 5 mg/d (high dose)
Number of subjects: 523
Study 28560779 — intervention group
Group type: COMPARATOR
Intervention: Comparison between high and low dose groups
Number of subjects: 523
Study 24711660 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 86
Study 24711660 — intervention group
Group type: COMPARATOR
Intervention: Balance and tone training (BAT)
Number of subjects: 86
Study 24711660 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 86
Study 24342146 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical BC-819 instillations
Number of subjects: 47
Study 21955815 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (10 mg bid)
Number of subjects: 257
Study 21955815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257
Study 19182688 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus medication change
Number of subjects: 334
Study 19182688 — intervention group
Group type: COMPARATOR
Intervention: Medication alone
Number of subjects: 334
Study 19182688 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative SSRI plus CBT
Number of subjects: 334
Study 19182688 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine plus CBT
Number of subjects: 334
Study 19182688 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative SSRI
Number of subjects: 334
Study 19182688 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 334
Study 17440209 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-discrepant situations (e.g., having dirty shoes)
Number of subjects: 0
Study 17440209 — intervention group
Group type: EXPERIMENTAL
Intervention: Subliminal priming to enhance goal accessibility
Number of subjects: 0
Study 17440209 — intervention group
Group type: COMPARATOR
Intervention: Control situations (not specified)
Number of subjects: 0
Study 16041450 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary guidance
Number of subjects: 621
Study 16041450 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral changes
Number of subjects: 621
Study 16041450 — intervention group
Group type: EXPERIMENTAL
Intervention: Better detection and hygienic measures
Number of subjects: 621
Study 16041450 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 621
Study 11515768 — intervention group
Group type: EXPERIMENTAL
Intervention: SB MMR
Number of subjects: 301
Study 11515768 — intervention group
Group type: COMPARATOR
Intervention: Merck MMR
Number of subjects: 301
Study 9489597 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (17 mg kg[‐1] min[‐1], infusion period 30 min)
Number of subjects: 17
Study 9489597 — intervention group
Group type: COMPARATOR
Intervention: Angiotensin II (5.0 ng kg[‐1] min[‐1], infusion period 75 min)
Number of subjects: 17
Study 8157352 — intervention group
Group type: EXPERIMENTAL
Intervention: Active multi-vitamin multi-mineral supplement
Number of subjects: 3318
Study 8157352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3318
Study 3139884 — intervention group
Group type: EXPERIMENTAL
Intervention: Rebreathing (paper bag method)
Number of subjects: 12
Study 3139884 — intervention group
Group type: COMPARATOR
Intervention: Normal ventilation (control)
Number of subjects: 12
Study 3139884 — intervention group
Group type: EXPERIMENTAL
Intervention: Rebreathing in a semiclosed tube system
Number of subjects: 12
Study 3139884 — intervention group
Group type: COMPARATOR
Intervention: Open tube system (control)
Number of subjects: 12
Study 29982631 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab maintenance therapy
Number of subjects: 0
Study 29982631 — intervention group
Group type: COMPARATOR
Intervention: Non-responders to induction treatment
Number of subjects: 0
Study 29982631 — intervention group
Group type: COMPARATOR
Intervention: Responders to induction treatment
Number of subjects: 0
Study 29982631 — intervention group
Group type: COMPARATOR
Intervention: Colectomy
Number of subjects: 0
Study 28617368 — intervention group
Group type: EXPERIMENTAL
Intervention: teberif (BCD‐033, interferon beta‐1)
Number of subjects: 163
Study 28617368 — intervention group
Group type: EXPERIMENTAL
Intervention: rebif (interferon beta‐1a)
Number of subjects: 163
Study 28617368 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 163
Study 25762810 — intervention group
Group type: EXPERIMENTAL
Intervention: RT+CR
Number of subjects: 126
Study 25762810 — intervention group
Group type: COMPARATOR
Intervention: RT
Number of subjects: 126
Study 23500894 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based training (IBT) in cognitive behavioural therapy (CBT) theory, assessment and formulation (approximately three hours over the course of one month)
Number of subjects: 63
Study 23500894 — intervention group
Group type: COMPARATOR
Intervention: Delayed training control group
Number of subjects: 63
Study 21687923 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrating plate via reciprocation therapy
Number of subjects: 50
Study 19628106 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 162
Study 19628106 — intervention group
Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 162
Study 19628106 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet + Exercise
Number of subjects: 162
Study 19628106 — intervention group
Group type: COMPARATOR
Intervention: Parental compliance (PedsQL completed at baseline)
Number of subjects: 162
Study 19628106 — intervention group
Group type: COMPARATOR
Intervention: Parental compliance (PedsQL completed at end of intervention)
Number of subjects: 162
Study 17115983 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 50 mg/day
Number of subjects: 51
Study 17115983 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/day
Number of subjects: 51
Study 17115983 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 200 mg/day
Number of subjects: 51
Study 17115983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 15656433 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic vibration applied continuously for 30 minutes to the top of the posts in the test groups.
Number of subjects: 40
Study 15656433 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ultrasonic vibration applied).
Number of subjects: 40
Study 10784221 — intervention group
Group type: EXPERIMENTAL
Intervention: C-peptide (600 nmol/24 h)
Number of subjects: 21
Study 10784221 — intervention group
Group type: EXPERIMENTAL
Intervention: C-peptide
Number of subjects: 21
Study 10784221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 8973778 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacidipine
Number of subjects: 2300
Study 8973778 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 2300
Study 1325520 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive group
Number of subjects: 11
Study 1325520 — intervention group
Group type: COMPARATOR
Intervention: Normotensive group
Number of subjects: 11
Study 1325520 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups during 24-h ambulatory recording
Number of subjects: 11
Study 1325520 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups in luteal phase
Number of subjects: 11
Study 3918683 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rehydration fluid plus breast feeding
Number of subjects: 26
Study 3918683 — intervention group
Group type: COMPARATOR
Intervention: Oral rehydration fluid alone
Number of subjects: 26
Study 31993736 — intervention group
Group type: COMPARATOR
Intervention: Drug-eluting stents (DES)
Number of subjects: 883
Study 31993736 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB)
Number of subjects: 883
Study 30247704 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy 25(OH)D >125 nmol/L
Number of subjects: 798
Study 30247704 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord blood (UCB) 25(OH)D
Number of subjects: 798
Study 30247704 — intervention group
Group type: EXPERIMENTAL
Intervention: UCB 25(OH)D
Number of subjects: 798
Study 30247704 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant 25(OH)D
Number of subjects: 798
Study 27598983 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index diet (LGI)
Number of subjects: 20
Study 27598983 — intervention group
Group type: COMPARATOR
Intervention: High glycemic index diet (HGI)
Number of subjects: 20
Study 26293927 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic Voiding Programme (SVP)
Number of subjects: 0
Study 22338607 — intervention group
Group type: COMPARATOR
Intervention: Exercise and placebo (n =20)
Number of subjects: 70
Study 22338607 — intervention group
Group type: COMPARATOR
Intervention: Exercise and isoflavone (n =20)
Number of subjects: 70
Study 22338607 — intervention group
Group type: COMPARATOR
Intervention: Isoflavones (n =15)
Number of subjects: 70
Study 22338607 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n =15)
Number of subjects: 70
Study 21778474 — intervention group
Group type: EXPERIMENTAL
Intervention: Public health nurse case management plus Medicaid intervention
Number of subjects: 432
Study 21778474 — intervention group
Group type: COMPARATOR
Intervention: Wait-control group
Number of subjects: 432
Study 19408736 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 58
Study 19408736 — intervention group
Group type: COMPARATOR
Intervention: Control (no prophylactic treatment)
Number of subjects: 58
Study 17344509 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quintile of maternal total vitamin D intake
Number of subjects: 1212
Study 17344509 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower maternal total vitamin D intakes in pregnancy
Number of subjects: 1212
Study 17344509 — intervention group
Group type: COMPARATOR
Intervention: Maternal vitamin D intake
Number of subjects: 1212
Study 15140776 — intervention group
Group type: EXPERIMENTAL
Intervention: budesonide 9 mg daily
Number of subjects: 143
Study 15140776 — intervention group
Group type: EXPERIMENTAL
Intervention: prednisolone 7.5 mg daily
Number of subjects: 143
Study 15140776 — intervention group
Group type: EXPERIMENTAL
Intervention: budesonide 3 mg daily
Number of subjects: 143
Study 15140776 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 143
Study 12095492 — intervention group
Group type: EXPERIMENTAL
Intervention: leuprolide acetate plus tibolone (group A)
Number of subjects: 120
Study 12095492 — intervention group
Group type: EXPERIMENTAL
Intervention: hysterectomy with bilateral oophorectomy (group B)
Number of subjects: 120
Study 12095492 — intervention group
Group type: COMPARATOR
Intervention: healthy control women (group C)
Number of subjects: 120
Study 12095492 — intervention group
Group type: COMPARATOR
Intervention: comparison of groups A and B with group C
Number of subjects: 120
Study 10521759 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic methotrexate administration
Number of subjects: 100
Study 10521759 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic salpingostomy
Number of subjects: 100
Study 8704532 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypericum extracts (St John's wort)
Number of subjects: 1757
Study 8704532 — intervention group
Group type: COMPARATOR
Intervention: Standard antidepressants
Number of subjects: 1757
Study 1660411 — intervention group
Group type: EXPERIMENTAL
Intervention: Retroperitoneal lymph node dissection (RPLND) prior to chemotherapy
Number of subjects: 152
Study 1660411 — intervention group
Group type: EXPERIMENTAL
Intervention: Retroperitoneal lymph node dissection (RPLND) after initial chemotherapy
Number of subjects: 152
Study 6131630 — intervention group
Group type: EXPERIMENTAL
Intervention: Fazadinium (1 mg . kg‐1)
Number of subjects: 30
Study 6131630 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcuronium (0.2 mg . kg‐1)
Number of subjects: 30
Study 6131630 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium (0.08 mg . kg‐1)
Number of subjects: 30
Study 4072094 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin
Number of subjects: 0
Study 29110179 — intervention group
Group type: EXPERIMENTAL
Intervention: Triheptanoin
Number of subjects: 23
Study 29110179 — intervention group
Group type: COMPARATOR
Intervention: Vegetable oil (placebo)
Number of subjects: 23
Study 27571052 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute consumption of wild blueberries
Number of subjects: 18
Study 27571052 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily consumption of wild blueberries for 30 days
Number of subjects: 18
Study 27571052 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute consumption on day 1
Number of subjects: 18
Study 27571052 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic consumption on day 30
Number of subjects: 18
Study 27571052 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-individual variability in plasma and urine
Number of subjects: 18
Study 24519863 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril plus allopurinol
Number of subjects: 44
Study 24519863 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 44
Study 22067666 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% StarPharma LTD 7013 gel (VivaGel)
Number of subjects: 54
Study 22067666 — intervention group
Group type: COMPARATOR
Intervention: Placebo (carbopol gel without StarPharma LTD 7013)
Number of subjects: 54
Study 21091611 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone
Number of subjects: 136
Study 21091611 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 136
Study 21091611 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 18391867 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent implantation
Number of subjects: 101
Study 16418138 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal therapy (target: <120/80 mm Hg)
Number of subjects: 23
Study 16418138 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (target: <140/90 mm Hg)
Number of subjects: 23
Study 12791360 — intervention group
Group type: EXPERIMENTAL
Intervention: Venturi suction drainage system
Number of subjects: 3124
Study 10789885 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine (4 mg)
Number of subjects: 16
Study 10789885 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100 mg)
Number of subjects: 16
Study 10789885 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (100 mg)
Number of subjects: 16
Study 8876347 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO-enriched diet
Number of subjects: 0
Study 8876347 — intervention group
Group type: COMPARATOR
Intervention: Mixed diet (controls)
Number of subjects: 0
Study 1647920 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing position
Number of subjects: 7
Study 1647920 — intervention group
Group type: COMPARATOR
Intervention: Lying position
Number of subjects: 7
Study 1647920 — intervention group
Group type: EXPERIMENTAL
Intervention: Both positions
Number of subjects: 7
Study 6581755 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 39
Study 6581755 — intervention group
Group type: COMPARATOR
Intervention: Moxalactam
Number of subjects: 39
Study 31587090 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised dosing algorithm based on warfarin PK/PD model
Number of subjects: 31
Study 31587090 — intervention group
Group type: COMPARATOR
Intervention: Conventional weight-based dosing
Number of subjects: 31